ACR Winter Rheumatology Symposium

Winter Rheumatology Symposium

In Person

Logo

About the Event

Date:2025 | To Be Announced

Location:To Be Announced

Credit:TBA

On Demand:To Be Announced

The Winter Rheumatology Symposium (WRS) provides up-to-date, practical clinical information on the diagnosis and management of patients with rheumatic and immune disorders.

Target Audience
Rheumatologists, members of the interprofessional team, and other healthcare providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date clinical information on the diagnosis and management of patients with rheumatic and immunologic diseases
  • Describe the most current information regarding the pathophysiology underlying rheumatic disorders

For information about the previous meeting, see the Winter Rheumatology Symposium 2024 section below.


Program Schedule & Syllabi

To Be Announced

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.


Registration Fees

To Be Announced


Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.
See industry engagement opportunities and benefits of supporting the ACR

CME

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.

Designation Statement
The American College of Rheumatology designates this Live Activity for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by (to be announced).

MOC

MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by (to be announced).

ABIM CME/ MOC accredited

Instructions to Claim CME/MOC Credit

  • Login to your My Credit page
  • Locate Winter Rheumatology Symposium 2025 and click Claim Credit. Enter the amount of credit commensurate with your participation. (To view or update your credit, select View Credit.)
  • After claiming CME, you will be asked if you wish to claim ABIM MOC. If you select Yes, you will be prompted to enter or confirm your MOC Diplomate Number and date of birth. Then you will select areas of key learning and enter a reflective statement.

The deadline to claim CME credit and MOC points for Winter Rheumatology Symposium 2025 is (to be announced).

Credit claiming is available after the activity starts.

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

*All of the relevant financial relationships listed for these individuals have been mitigated.

Winter Rheumatology Symposium 2025 disclosures to be announced.

The Winter Rheumatology Symposium 2024 was an in-person only event held from January 28–February 1, 2024, in Snowmass Village, Colorado.


Target Audience
Rheumatologists, physicians, and other health care providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date clinical information on the diagnosis and management of patients with rheumatic and immunologic diseases
  • Describe the most current information regarding the pathophysiology underlying rheumatic disorders

Program Schedule & Syllabi

Winter Rheumatology 2024 Program Schedule

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, log in and go to My Learning.


CME & MOC Information

CME

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.

Designation Statement
The American College of Rheumatology designates this Live Activity for a maximum of 21.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by January 28, 2025, at 11:59 PM ET.

MOC

MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by January 28, 2025, at 11:59 PM ET.

ABIM CME/ MOC accredited

Instructions to Claim CME/MOC Credit

  • Login to your My Credit page
  • Locate Winter Rheumatology Symposium 2024 and click Claim Credit. Enter the amount of credit commensurate with your participation. (To view or update your credit, select View Credit.)
  • After claiming CME, you will be asked if you wish to claim ABIM MOC. If you select Yes, you will be prompted to enter or confirm your MOC Diplomate Number and date of birth. Then you will select areas of key learning and enter a reflective statement.

The deadline to claim CME credit and MOC points for Winter Rheumatology Symposium 2024 is January 28, 2025, at 11:59 PM ET.

Credit claiming is available after the activity starts.


Financial Relationships Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

Winter Rheumatology Symposium 2024 Disclosures

*All of the relevant financial relationships listed for these individuals have been mitigated.


Corporate Support

The American College of Rheumatology thanks Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC for supporting the Winter Rheumatology Symposium 2024 with an independent medical education grant.

Interested in exhibiting at WRS?
Review the Exhibitor and Sponsorship Prospectus and attendee demographics.

Exhibits and Sponsorship Questions?
Contact Kat Dennis (kdennis@rheumatology.org).

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies